The Food and Drug Administration has approved a new drug, Cobenfy, for schizophrenia that is said to have fewer side effects than current medications. This has been a major development for patients like Tiffany who have struggled with severe side effects from traditional antipsychotic drugs. Tiffany shares her personal experience and how this new medication gives her hope for a better quality of life.
Schizophrenia: New Drug Approved by FDA Offers Hope for Patients
Background
Schizophrenia is a severe mental disorder characterized by hallucinations, delusions, disorganized thinking, and social withdrawal. Antipsychotic medications have been the mainstay of treatment for schizophrenia, but they often cause significant side effects, including movement disorders, metabolic problems, and cognitive impairment.
FDA Approves New Drug for Schizophrenia
In February 2023, the US Food and Drug Administration (FDA) approved a new medication called Cobenfy (asenapine sublingual tablet) for the treatment of schizophrenia. Cobenfy is a novel antipsychotic that is designed to have fewer side effects than traditional medications.
Trials have shown that Cobenfy is effective in reducing the symptoms of schizophrenia and improving overall functioning. Unlike other antipsychotics that are given as injections or tablets, Cobenfy is administered sublingually (under the tongue), which allows for faster absorption and a potential reduction in side effects.
Patient Perspective
For patients like Tiffany, who has struggled with severe side effects from traditional antipsychotic drugs, Cobenfy offers a beacon of hope. Tiffany has experienced significant improvement in her symptoms and quality of life since starting Cobenfy.
"It's like a weight has been lifted off my shoulders," said Tiffany. "I'm able to think more clearly, I'm more social, and I'm finally starting to feel like myself again."
Top 5 FAQs
1. What are the potential benefits of Cobenfy over other antipsychotics?
Cobenfy is designed to have fewer side effects, including movement disorders, metabolic problems, and cognitive impairment.
2. How is Cobenfy administered?
Cobenfy is administered sublingually, which means it is placed under the tongue. This allows for faster absorption and a potential reduction in side effects.
3. What are the common side effects of Cobenfy?
The most common side effects of Cobenfy include headache, nausea, vomiting, dizziness, and drowsiness.
4. Is Cobenfy approved for use in all patients with schizophrenia?
While Cobenfy is generally well-tolerated, it may not be appropriate for all patients with schizophrenia. It is important to discuss your individual needs with your healthcare provider.
5. What is the long-term outlook for patients taking Cobenfy?
Studies are ongoing to determine the long-term safety and efficacy of Cobenfy. However, the short-term results have been promising, and patients like Tiffany are hopeful for a brighter future.
India's Minister of Petroleum and Natural Gas, Hardeep Singh Puri, is exploring projects in Norway, where the government is funding the largest carbon storage project in the country. This aligns with India's ambitious energy transition agenda. The project involves capturing CO2 emissions from industrial sources and storing them underground, which can help decarbonise industries and mitigate climate change.
A recent study published in The BMJ found that intermittent fasting might be just as effective as traditional calorie-restricted diets, particularly for those with pre-existing health conditions. Despite the limitations of the study, which focused on trials lasting less than 24 weeks, it provides some indication that intermittent fasting can result in weight loss and improved cardiometabolic risk factors. However, the study authors caution that longer-term research is needed to confirm these effects.
Scientific research has found that consistent meditation can provide numerous physical and mental health benefits. By focusing one's attention and letting thoughts come and go without judgment, meditation can reduce stress, anxiety, and depression, while also improving focus, concentration, and sleep quality. Even brief daily meditation sessions have been found to have positive effects on mood and cognitive function, making it a valuable tool for anyone new to the practice or looking to manage their mental health.
"Kerala's Nipah Contact List Surges to 425, Health Workers and Isolation Measures Strengthened" The Nipah contact list in Kerala has reached a staggering 425 individuals, with Malappuram district recording the highest number of contacts. 12 individuals in Malappuram and one in Palakkad are currently undergoing treatment, with a special focus on mental health support for the public. In a high-level review meeting, it was decided that only samples from contacts would be tested in Palakkad and measures such as ambulance readiness and contact tracing intensified.
A team of archaeologists from the Vindolanda Charity Trust in northern England has discovered a collection of Roman shoes, all measuring over 30 centimeters long, at the Magna Roman Fort in Northumberland. These "giant" shoes, equivalent to size 49 in Europe and size 15 in the US, have left experts baffled as they search for an explanation for their unusual size. The team is now speculating on who may have worn these shoes, and what their presence at this particular site may signify. This discovery sheds new light on the daily life of Roman soldiers stationed at the Hadrian's Wall World Heritage Site.
"India's Young Cricket Captain Leads the Way: Breaking Records and Comparisons to Legends" Shubman Gill has stepped up as the new captain of the Indian cricket team and proves he is turning out to be a star in his own right. In just his 34th Test, Gill surpassed Sachin Tendulkar's highest score and has outperformed Virat Kohli as well. His leadership skills and batting prowess have earned him recognition and praise from fans and even exhausted opponents. Despite criticism, Gill stayed true to his own tactics and proved himself with an epic inning of 269. He has set a high standard for himself and the Indian team as they continue the series against England.
WHO has released its first-ever global guideline on managing sickle cell disease (SCD) during pregnancy, highlighting the dangers faced by women and their babies. SCD is an inherited blood disorder with potentially fatal consequences, and the health risks intensify during pregnancy. The new guideline aims to improve outcomes for pregnant women with SCD and calls for more investment in evidence-based treatments and disease awareness. With SCD on the rise globally, increasing numbers of maternity care providers need to be equipped to handle its challenges.
On Thursday, March 19 at 5:01 a.m. ET, the vernal equinox or the first day of spring will take place in the Northern Hemisphere. This marks the beginning of the season of longer days and warmer weather as the sun's rays fall directly on the equator. Despite popular belief, day and night are not exactly the same length on the equinox due to atmospheric refraction. The summer and winter solstices and the autumnal equinox also have significant impacts on the Earth's tilt and the length of daylight hours.
A new, inexpensive Arduino-based logger has been developed for accurately mapping the depths of water bodies. By using budget-friendly hardware such as a GPS module and an SD card, combined with a standard NMEA capable echolot sounder, this device is accessible and practical for scientists, recreational enthusiasts, and more. With the added use of Python and matplotlib, users can now easily transform the collected data into detailed depth maps, revealing vital information about water levels and shallow spots in various environments.
After a 28-hour journey through space, Group Captain Shukla has become the first Indian to board the International Space Station (ISS). Accompanied by three other astronauts from the Axiom-4 mission, the ISS is now hosting a total of 11 people. Shukla was welcomed with hugs by the astronauts already stationed at the ISS and presented with the astronaut number 634. As the pilot of the mission, Shukla was given a number ahead of his fellow rookie astronauts and was offered a liquid diet to refresh himself before exploring the six-bedroom facility in space.